L. Baker

发表

Quantitative shear wave ultrasound elastography: initial experience in solid breast masses

Kim Thomson, Lee Baker, Alastair Thompson, 2010, Breast Cancer Research.

Differentiating benign from malignant solid breast masses: value of shear wave elastography according to lesion stiffness combined with greyscale ultrasound according to BI-RADS classification

A. Thompson, C. Purdie, L. Jordan, 2012, British Journal of Cancer.

Invasive breast cancer: relationship between shear-wave elastographic findings and histologic prognostic factors.

A. Thompson, C. Purdie, L. Jordan, 2012, Radiology.

Characterization, chemical optimization and anti-tumor activity of a tubulin poison identified by a p53-based phenotypic screen

A. Slawin, A. Thompson, D. Lane, 2008, Cell cycle.

WP 1 : Cell Biology , Autopoiesis and Biological Design Patterns D 1 . 4 : Mathematical Models of Gene Expression Computing

Chrystopher L. Nehaniv, M. Schilstra, A. Thompson, 2022 .

Sentinel node biopsy in breast cancer has a greater node positivity rate than axillary node sample: results from a retrospective analysis.

C. Purdie, K. Brauer, L. Baker, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Multiparameter DNA content analysis identifies distinct groups in primary breast cancer

A. Thompson, C. Purdie, M. Sales, 2013, British Journal of Cancer.

Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy

A. Thompson, K. Murray, F. Paulin, 2010, British Journal of Cancer.

Dose‐intensified treatment of Burkitt lymphoma and B‐cell lymphoma unclassifiable, (with features intermediate between diffuse large B‐cell lymphoma and Burkitt lymphoma) in young adults (<50 years): A comparison of two adapted BFM protocols

J. Delabie, H. Holte, P. Mahendra, 2010, American journal of hematology.

Factors influencing a second myeloid malignancy in patients with Philadelphia-negative -7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia.

M. Sales, L. Baker, M. Groves, 2011, Cancer genetics.

Safety and diagnostic accuracy of image guided biopsies in patients with small renal masses

L. Baker, G. Nabi, I. El-Mokadem, 2016 .

High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer

C. Purdie, L. Baker, A. Thompson, 2010, International journal of cancer.

Histological evaluation of AMPK signalling in primary breast cancer

Philip R Quinlan, Lee Baker, Alastair M Thompson, 2009, BMC Cancer.

Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator

Lee Baker, Alastair Thompson, Sonia Lain, 2007, Cancer cell.

Supplemental Data Discovery, in Vivo Activity, and Mechanism of Action of a Small-molecule P53 Activator Supplemental Experimental Procedures

A. Thompson, D. Lane, N. Westwood, 2022 .

DNA polymerase θ up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability

A. Thompson, M. Lacroix-Triki, R. Wood, 2010, Proceedings of the National Academy of Sciences.

FGFR2 protein expression in breast cancer: nuclear localisation and correlation with patient genotype

A. Thompson, C. Palmer, C. Purdie, 2011, BMC Research Notes.

MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism

A. Thompson, D. Lane, C. Purdie, 2008, BMC Cancer.

Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial

L. Pusztai, A. Thompson, J. Dewar, 2011, Breast Cancer Research and Treatment.

Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study

A. Thompson, J. Dewar, C. Purdie, 2010, British Journal of Cancer.

The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer

A. Thompson, T. Crook, C. Purdie, 2009, British Journal of Cancer.

p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients

A. Thompson, D. Lane, C. Purdie, 2011, Breast Cancer Research.

Diagnostic accuracy of image-guided biopsies in small (<4 cm) renal masses with implications for active surveillance: a systematic review of the evidence.

L. Baker, G. Nabi, C. Paterson, 2018, The British journal of radiology.

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer

A. Thompson, D. Lamont, F. Paulin, 2012, British Journal of Cancer.

Long-term oncologic outcomes of laparoscopic radical nephrectomy for kidney cancer resection: Dundee cohort and metaanalysis of observational studies

L. Baker, G. Nabi, C. Goodman, 2011, Surgical Endoscopy.

p53 mutation, deprivation and poor prognosis in primary breast cancer

A. Thompson, J. Dewar, C. Purdie, 2010, British Journal of Cancer.

The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancer

F. Fuller-Pace, A. Thompson, C. Purdie, 2010, Oncogene.

NF-kB Complex Activation and Association of αB-Crystallin and Vimentin with Poor Prognosis in Primary Breast Cancer.

C. Purdie, P. Quinlan, S. Bray, 2009 .

αB-crystallin, vimentin and increased p53 expression levels in breast cancer is associated with poor prognosis.

C. Purdie, P. Quinlan, S. Bray, 2009 .

Author's response to reviews Title: MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism Authors:

D. Lane, C. Purdie, A. Munro, 2008 .

p 53 mutant breast cancer patients expressing p 53 γ have as good a prognosis as wild-type p 53 breast cancer patients

A. Thompson, D. Lane, C. Purdie, 2017 .

Invasive breast cancer: relationship between shear-wave elastographic findings and histologic prognostic factors.

A. Thompson, C. Purdie, L. Jordan, 2012, Radiology.

Factors influencing a second myeloid malignancy in patients with Philadelphia-negative -7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia.

M. Sales, L. Baker, M. Groves, 2011, Cancer genetics.